argenx Gets FDA Nod for VYVGART Hytrulo in CIDP Indication June 26, 2024 AutoBot News 0 FDA has approved argenx’s VYVGART Hytrulo for a new indication, treating chronic inflammatory demyelinating polyneuropathy.